Stephan Weidinger, MD, PhD, discusses 5-year ADlong data showing durable skin clearance and itch control with lebrikizumab in atopic dermatitis.
Stephan Weidinger, MD, PhD
Advertisement
Stephan Weidinger, MD, PhD, professor and chair for Dermatology at the Christian-Albrechts-University and director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein.
Articles by Stephan Weidinger, MD, PhD
This interview with Stephan Weidinger, MD, PhD, at AAD 2026 highlights new data on lebrikizumab
In this set of interviews, 6 leaders in the field of dermatology highlight their experiences at the 2025 EADV Congress.
Weidinger discusses results from a pair of late-breaking presentations on temtokibart in atopic dermatitis from EADV 2025.
Advertisement
Latest Updated Articles
Expert Perspectives: Top News in Dermatology from EADV Congress 2025September 30th 2025
Advertisement
Advertisement
Trending on HCPLive
1
2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics
2
Noninvasive Models Underestimate CSPH in MASH Cirrhosis vs HVPG
3
Once-Monthly Efimosfermin Improves Fibrosis Markers in Phase 2 MASH Study
4
Fazirsiran Reduces Liver Z-AAT Burden in AATD Liver Disease
5